sglt2 inhibitors vs glp-1 agonists and receptor agonists: a sound combination The Role of SGLT 2

But, in his nomination hearings, Oz failed to make any GLP-1 commitments, suggesting he may toe the line with Kennedy on any moves in this area

Lancet Diabetes Endocrinol 2017;5:25160

(China) Biocon (India) Altimmune (US) Viking Therapeutics (US) Recent Industry Developments January 2026: Novo Nordisk received US and EU regulatory approval for Wegovy High-Dose (7.2 mg), expanding treatment options within its obesity portfolio

Some people do extremely well on them

Research indicates that managing type 2 diabetes involves focusing on a diet rich in high-fiber foods like vegetables, fruits, legumes, and whole grains while limiting the intake of saturated fatty acids

Look into Medicaid patient prescription assistance programs, which may be offered by your state or nonprofit organizations